Aug 2025· Acta Pharmaceutica Sinica B· Vol 15, pp. 5758 - 5771· 12 citations· 69 references
Medicine
TL;DR
CarsiDock-Cov is presented, a new paradigm distinguishing itself as the first deep learning (DL)-guided approach for covalent docking, offering an automated and efficient solution that shows considerable promise for accelerating covalent drug discovery and design.
Abstract
The interest in covalent drugs has resurged in recent decades, spurring the development of numerous specialized computational docking tools to facilitate covalent ligand design and screening. Herein, we present CarsiDock-Cov, a new paradigm distinguishing itself as the first deep learning (DL)-guided approach for covalent docking. CarsiDock-Cov retains the core components of its non-covalent predecessor, leveraging a DL model pretrained on millions of docking complexes to predict protein–ligand distance matrices, along with a dedicated-designed geometric optimization procedure to convert these distances into refined binding poses. Additionally, it incorporates several key enhancements specifically tailored to optimize the protocol for covalent docking applications. Our approach has been extensively validated on multiple public datasets regarding the docking and screening of covalent ligands, and the results indicate that our approach not only achieves comparably improved applicability compared to its non-covalent predecessor, but also exhibits competitive performance against various state-of-the-art covalent docking tools. Collectively, our approach represents a significant advance in covalent docking methodology, offering an automated and efficient solution that shows considerable promise for accelerating covalent drug discovery and design.
Results indicate that 2D-based docking-score surrogate modeling can provide a reproducible and retrainable strategy for large-scale structure-based virtual screening by concentrating docking resources on a smaller, enriched subset of compounds.
Jongkeun Choi· International Journal of Mol...· 0 citations
DeepCGASPred is a cyclic GMP-AMP synthase (cGAS)-specific deep learning scoring function that integrates three-dimensional convolutional neural networks with multi-head attention mechanisms and composite structural descriptors, including Structural Protein–Ligand Interaction Fingerprints (SPLIF), hydrogen bond features, and extended connectivity fingerprints (ECFP).
Muhammad Junaid, Muhammad Zeeshan, Abbas Khan et al.· Discover Chemistry· 0 citations
Trimole-Hybrid is presented, a task-wise multimodal framework that addresses ADMET heterogeneity by selecting or combining predictors built from complementary molecular representations, and shows sensitivity to changes in essential functional motifs, suggesting its ability to capture ADMET-relevant molecular substructures.
Accurate prediction of drug-target binding affinity (DTA) is a key task in virtual screening. However, current computational methods face a key challenge: sequence-based approaches often fail to capture critical spatial information, while structure-based models rely on computationally expensive 3D coordinates, which restrict their scalability. To address this issue, we propose StructuraDTA, a novel multimodal framework that adopts an implicit structure modeling strategy. Instead of using static protein folding data, our method encodes drug molecular graphs via Graph Isomorphism Networks (GINs) to capture fine-grained topological features. Meanwhile, we optimize protein representations by integrating probabilistic structural priors into a pretrained language model, which effectively simulates thermodynamic conformational flexibility without relying on explicit 3D structural data. A bidirectional cross-attention mechanism is then used to dynamically align these heterogeneous feature modalities. Comprehensive evaluations on the Davis and KIBA benchmark datasets show that StructuraDTA stably outperforms state of-the-art comparison methods. Importantly, the model exhibits strong robustness in cold-start scenarios, and can accurately predict binding affinities for previously unseen drugs and targets. By retaining the predictive performance of structure based models while maintaining the high inference efficiency of sequence-based methods, we provide an accurate and scalable solution to accelerate genome-scale drug discovery research.
Junlin Xu, Ye Yuan, Menglong Hu et al.· IEEE journal of biomedical a...· 0 citations
What does it take to trust AI-driven HVAC optimization? Our AI Model Factory combines agents, machine learning, reinforcement learning and deterministic checks in a governed workflow designed for messy, real-world building data. The post We built an AI factory for HVAC control appeared first on GPT-Lab.
MIT News · Artificial Intelligence· news.mit.eduAug 18, 2026
A new method for surgically removing training examples from a model reveals that as datasets grow, the link between what a model learns and what it produces dissolves.
Microsoft Research Blog· microsoft.comJul 30, 2026
LLMs do not get smarter just by remembering more. EvoLib turns experience into evolving knowledge, taking reusable skills and insights that help models learn and adapt across tasks long after deployment. The post EvoLib: Turning experience into evolving knowledge appeared first on Microsoft Research.
MIT News · Artificial Intelligence· news.mit.eduAug 27, 2026
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.